Gene Therapy Market is expected to reach USD 28,167.69 million by 2030

Data Bridge Market Research analyzes that the global gene therapy market is expected to reach USD 28,167.69 million by 2030, at a CAGR of 18.3% during the forecast period. Product accounts for the most significant type segment in the market due to the growing use of exosome research products in diagnostics and therapeutics. Global Gene […]

Acute Bacterial Skin and Skin Structure Infections Market to Grow Substantially by 2032, Assesses DelveInsight | Key Companies – Melinta, AbbVie, Basilea, Motif Bio, Cubist, Paratek, Durata, The Medicine Company

New York, USA, Aug. 23, 2023 (GLOBE NEWSWIRE) — Acute Bacterial Skin and Skin Structure Infections Market to Grow Substantially by 2032, Assesses DelveInsight | Key Companies – Melinta, AbbVie, Basilea, Motif Bio, Cubist, Paratek, Durata, The Medicine Company The ABSSSI market is predicted to surge in the coming years owing to the improvement in […]

Overall Survival After Mohs Surgery for Early-Stage Merkel Cell Carcinoma

Key Points Question  How does surgical approach affect long-term patient survival after excision of pathologically confirmed, localized, early-stage Merkel cell carcinoma (MCC)? Findings  In this national cohort study of 2313 adults, excision of pathologically confirmed, localized, early-stage MCC with Mohs micrographic surgery was associated with significantly improved overall survival compared with wide local excision. Meaning  […]

Alcohol exposure before and during pregnancy is associated with reduced fetal growth: the Safe Passage Study

Study design This study was embedded in the Safe Passage Study, a prospective cohort study, conducted between 2007 and 2016 [23]. The total cohort included 12,000 pregnant women, recruited from predefined communities at high risk for prenatal alcohol use (USA and South Africa). The detailed study protocol is described elsewhere [23]. Previous studies in the […]

Inhaler combination outperforms others in reducing COPD exacerbation, cardiovascular risks

August 23, 2023 3 min read Source/Disclosures Disclosures: The study authors report no relevant financial disclosures. Blagev reports no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . <button type="button" class="btn […]

Circulating microvesicles across a population with various degree of cardiovascular burden are associated with systolic blood pressure

Abstract Circulating microvesicles (MVs) have been studied in heterogeneous, divergent, and rather small patient populations with cardiovascular risk . Therefore, we measured endothelial (EMVs), platelet (PMVs) and erythrocyte (RMVs) MVs in patients with divergent cardiovascular risk. We then compared them to coronary artery disease (CAD) and healthy subjects and identified independent MVs’ predictors. We enrolled […]

Vlad the Impaler may have shed tears of blood

Chemical analysis of letters written by the Romanian prince who may have inspired the novel Dracula, has revealed that he may have shed tears of blood due to a medical condition called haemolacria. Scientists from the University of Catania in Italy used non-invasive sampling techniques to extract and analyse 500 peptides and 16 proteins from […]

Study Reveals Body’s Ability to Restore Red Blood Cells and Bone After Space Travel

Red blood cells. (IANS) A study of 14 astronauts indicates that space travel depletes red blood cells and bone. However, the body can eventually restore them on Earth with the assistance of fat stored in the bone marrow. This discovery has potential benefits for health both in space and on Earth. The study, published in […]

Texas Heart Institute receives $1.14 million grant to develop first-in-class drug to treat cardiovascular disease

The National Heart, Lung, and Blood Institute (NHLBI) recently awarded The Texas Heart Institute® (THI) a two-year, $1.14 million grant to develop a novel, first-in-class drug to treat cardiovascular disease (CVD) as a significant improvement to current treatment regimens -; specifically for adverse events arising from atherosclerosis. Cardiovascular disease is the leading cause of death […]

Aspirin can help reduce risk of second heart attack, but study finds less than half of eligible adults take it

(CNN) — For adults who have survived a heart attack or stroke, taking aspirin regularly may reduce the risk of another cardiovascular event. But a new study suggests that less than half of these cardiovascular disease patients around the world are using aspirin to prevent a new event. Among people with a history of cardiovascular disease who were surveyed […]